Fig. 3From: A real-world study of acute and preventive medication use, adherence, and persistence in patients prescribed fremanezumab in the United StatesNumber of acute medication prescriptions analyzed via individual month post-fremanezumab initiation. BL baseline. P values calculated between individual months and baseline values via paired t-test. aP < 0.001Back to article page